Sort
25,944 grants matching “neurodegeneration”
Rescuing âº-synuclein toxicity through neuron-specific enhancement of autophagy
$201,960Jason Paul Chua · Johns Hopkins University · K08 · FY2025 · NS
Rescuing âº-synuclein toxicity through neuron-specific enhancement of autophagy
$201,960Jason Paul Chua · Johns Hopkins University · K08 · FY2023 · NS
Neural, Inflammatory, and Genomic Mechanisms Underlying Risk for Depression in Adolescence
$201,960George Michael Slavich · University Of California Los Angeles · K08 · FY2017 · MH
Rescuing âº-synuclein toxicity through neuron-specific enhancement of autophagy
$201,960Jason Paul Chua · Johns Hopkins University · K08 · FY2024 · NS
Identifying novel therapeutics for early onset dystonia
$201,957David Cristopher Bragg · Massachusetts General Hospital · R21 · FY2008 · NS
Examination of the bidirectional relationship between hearing loss and Alzheimer Disease pathology
$201,937Daniel A Llano · University Of Illinois At Urbana-Champaign · R21 · FY2021 · DC
Microglia: Role in Motoneuron Degeneration/Regeneration
$201,881University Of Florida · R21 · FY2005 · NS
Characterization and Use of Fluorescent Endocannabinoid Transporter Substrates
$201,875Michael P. Kavanaugh · University Of Montana · R21 · FY2008 · DA
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
$201,816Maj-Linda B Selenica · University Of Kentucky · P20 · FY2024 · GM
Role of LRRK2 in immunity in a nonhuman primate model of SIV
$201,747Krystal Vail · Tulane University Of Louisiana · K01 · FY2025 · OD
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS
$201,580University Of Minnesota Twin Cities · R01 · FY2001 · DA
Validation of the PGE2 EP4 receptor as a therapeutic target in AD
$201,556Katrin I Andreasson · Stanford University · R21 · FY2009 · AG
Identification of proteins in plasma lipoproteins as biomarkers to aid in diagnosing and predicting progression of Alzheimer's disease in older adults
$201,509Danni Li · University Of Minnesota · R21 · FY2020 · AG
A High Throughput Screen for Inhibitors of Aggregation of the Alzheimer's Peptide
$201,450Michael H Hecht · Princeton University · R21 · FY2007 · AG
ORGANELLE MOVEMENT IN FAST AXONAL TRANSPORT
$201,435University Of Virginia Charlottesville · R01 · FY2000 · NS
Causes and consequences of differential mRNA localization to mRNP granules (equipment supplement)
$201,385Brian Matthew Zid · University Of California, San Diego · R35 · FY2020 · GM
Mitochondrial Mechanisms of Hypoxic Ischemic Neonatal Brain injury
$201,328Gary Fiskum · University Of Maryland Baltimore · P01 · FY2008 · HD
Interaction between epilepsy and AD: novel therapeutic strategies
$201,250Frances E Jensen · University Of Pennsylvania · R21 · FY2019 · NS
Role of type I interferon signaling in Zika virus infection of the brain
$201,250Susan R. Weiss · University Of Pennsylvania · R21 · FY2016 · NS
Molecular correlates of sub-regional thalamic degeneration in multiple sclerosis
$201,250Ranjan Dutta · Cleveland Clinic Lerner Com-Cwru · R21 · FY2023 · NS
Effect of enriched environment on ALS neurodegeneration
$201,250Columbia University Health Sciences · R21 · FY2005 · ES
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiation
$201,250E. Ashley Moseman · Duke University · R21 · FY2022 · AG
Regulation of LRRK2 in lysosomal stress response
$201,250Tso-Pang Yao · Duke University · R21 · FY2024 · NS
Molecular neuropathology of TDP-43 proteinopathies
$201,250Edward Byung-Ha Lee · University Of Pennsylvania · R21 · FY2017 · NS
Dysregulation of amyloid-β metabolism by impaired METTL3-m6A signaling in Alzheimer's Disease
$201,250Fanpeng Zhao · Case Western Reserve University · R21 · FY2024 · AG